首页> 中文期刊> 《陕西中医》 >利胆疏肝汤应用于恶性梗阻性黄疸介入治疗中疗效对比分析

利胆疏肝汤应用于恶性梗阻性黄疸介入治疗中疗效对比分析

         

摘要

目的:分析自拟利胆疏肝汤对于恶性梗阻性黄疸介入治疗患者的效果.方法:以在本院接受介入治疗的68例恶性梗阻性黄疸患者作为本次研究观察资料,将全部患者随机均分后分别纳入对照组与治疗组,对照组采取单纯介入治疗,治疗组在对照组的基础之上给予自拟利胆疏肝汤进行治疗;治疗1个疗程后对比两组患者的胆汁引流量、血清内毒素水平、肝胆功能系列化验指标.结果:治疗后两组肝胆功能指标及 PE水平均优于本组治疗前,差异具有统计学意义(P<0. 05);并且治疗后治疗组患者的肝胆功能指标及 PE水平均优于对照组,差异具有统计学意义(P<0.05).对照组胆汁引流量为(231.25 ± 102.14)ml/d,治疗组胆汁引流量为(378.36 ± 106.21) ml/d,治疗组引流量优于对照组(P<0.05).结论:利胆疏肝汤可明确提高介入治疗的疗效,对于改善患者肝胆功能具有理想效果.%Objective:To analyze the effect of Lidan Shugan decoction for patients with malignant obstructive jaundice.Methods:68 patients with malignant obstructive jaundice were treated with interventional therapy in our hospital as the study data,all patients were randomly divided into treatment group and control group,the control group took a simple interventional therapy,treatment group on the basis of the control group were treated with Li-dan Shugan decoction treatment;after a course of treatment,compared two groups of patients with biliary drainage, serum endotoxin levels and liver function test index series.Results:The two groups after treatment liver function in-dex and PE level were better than those of the group before treatment,the difference was statistically significant(P<0.05);and after treatment in patients with liver function index and PE level were better than the control group, the difference was statistically significant(P<0.05).The flow rate of bile in the control group was(231.25 ± 102. 14)ml/d,and the flow rate of bile in the treatment group was(378.36 ± 106.21)ml/d,and the flow rate of the treatment group was better than that of the control group(P<0.05).Conclusion:Lidan Shugan decoction can im-prove the curative effect of interventional therapy,and have ideal effect on improving the function of liver and gall-bladder.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号